找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Drug Discovery in Japan; Investigating the So Sadao Nagaoka Book 2019 Springer Nature Singapore Pte Ltd. 2019 Drug discovery.breakthrough.u

[复制链接]
楼主: Halcyon
发表于 2025-3-27 00:58:43 | 显示全部楼层
发表于 2025-3-27 02:17:06 | 显示全部楼层
发表于 2025-3-27 06:49:13 | 显示全部楼层
发表于 2025-3-27 11:55:49 | 显示全部楼层
发表于 2025-3-27 16:24:31 | 显示全部楼层
发表于 2025-3-27 19:22:07 | 显示全部楼层
发表于 2025-3-27 23:05:31 | 显示全部楼层
Nivolumab (Opdivo,. The new gene (PD-1), its function, and the possibility that its suppression can be used to block cancer growth were identified in the laboratory of Prof. Tasuku Honjo at Kyoto University, starting from a serendipitous basic science discovery. Despite concrete demonstrations by Honjo’s team of the
发表于 2025-3-28 03:41:23 | 显示全部楼层
Sources of Innovation of Drug Discovery in Japan and Its Implications,rojects in Japan in a unified framework, and discusses their potential implications on innovation management and policy. The focal issues of discussion are: (A) knowledge sources of the discovery projects; (B) the dynamic relationship between drug discovery and scientific progress; (C) coping with u
发表于 2025-3-28 09:48:12 | 显示全部楼层
发表于 2025-3-28 13:22:04 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-4 18:33
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表